# Versus Systems Inc.: overview

VS · Nasdaq · CIK 1701963 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vs.md) · [Financials](/companies/vs/financials.md) · [Filings](/companies/vs/filings.md) · [Insiders](/companies/vs/insiders.md)

Latest reported revenue: [$6.8k](/filings/0001213900-26-089786.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-089786).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [3.8](/filings/0001213900-25-110337.md) | [0.0 d](/filings/0001213900-26-044110.md) | [199](/filings/0001213900-26-057987.md) | [(176) d](/filings/0001213900-26-089786.md) | [0.0 d](/filings/0001213900-25-110337.md) | [2,160 d](/filings/0001213900-26-044110.md) | [17.3](/filings/0001213900-26-057987.md) | [6.8](/filings/0001213900-26-089786.md) |
| Gross margin | % | [100.0%](/filings/0001213900-25-110337.md) | not reported | [95.9%](/filings/0001213900-26-057987.md) | [(1120.3%) d](/filings/0001213900-26-089786.md) | not reported | [0.2% d](/filings/0001213900-26-044110.md) | [100.0%](/filings/0001213900-26-057987.md) | [21871.0%](/filings/0001213900-26-089786.md) |
| Operating margin | % | [(13748.0%)](/filings/0001213900-25-110337.md) | not reported | [(588.3%)](/filings/0001213900-26-057987.md) | [(533.4%) d](/filings/0001213900-26-089786.md) | not reported | [(54.2%) d](/filings/0001213900-26-044110.md) | [(4732.3%)](/filings/0001213900-26-057987.md) | [8712.4%](/filings/0001213900-26-089786.md) |
| Net margin | % | [(14575.6%)](/filings/0001213900-25-110337.md) | not reported | [(482.4%)](/filings/0001213900-26-057987.md) | [(382.0%) d](/filings/0001213900-26-089786.md) | not reported | [(44.7%) d](/filings/0001213900-26-044110.md) | [(3949.1%)](/filings/0001213900-26-057987.md) | [6938.8%](/filings/0001213900-26-089786.md) |
| Diluted EPS | $ per share | [(0.22)](/filings/0001213900-24-098269.md) | not reported | [(0.20)](/filings/0001213900-26-057987.md) | [0.14](/filings/0001213900-26-089786.md) | not reported | not reported | [(0.14)](/filings/0001213900-26-057987.md) | [0.10](/filings/0001213900-26-089786.md) |
| Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [769](/filings/0001213900-23-024078.md) | [1,109](/filings/0001213900-24-028552.md) | [271](/filings/0001213900-25-026006.md) | [57.3](/filings/0001213900-26-044110.md) | [2,183](/filings/0001213900-26-044110.md) |
| Gross margin | % | not reported | [44.4%](/filings/0001213900-24-028552.md) | [62.0%](/filings/0001213900-25-026006.md) | [29.7%](/filings/0001213900-26-044110.md) | [99.2%](/filings/0001213900-26-044110.md) |
| Operating margin | % | not reported | [(2044.6%)](/filings/0001213900-24-028552.md) | [(4002.1%)](/filings/0001213900-25-026006.md) | [(7923.5%)](/filings/0001213900-26-044110.md) | [(99.0%)](/filings/0001213900-26-044110.md) |
| Net margin | % | [(2322.0%)](/filings/0001213900-23-024078.md) | [(2026.7%)](/filings/0001213900-24-028552.md) | [(3513.3%)](/filings/0001213900-25-026006.md) | [(7056.2%)](/filings/0001213900-26-044110.md) | [(82.1%)](/filings/0001213900-26-044110.md) |
| Diluted EPS | $ per share | [(15.11)](/filings/0001213900-23-024078.md) | [(192.89)](/filings/0001213900-24-028552.md) | [(10.44)](/filings/0001213900-25-026006.md) | [(1.54)](/filings/0001213900-26-044110.md) | [(0.37)](/filings/0001213900-26-044110.md) |
| Free cash flow | $k | not reported | [(9,194)](/filings/0001213900-24-028552.md) | not reported | not reported | not reported |

- Revenue. XBRL Revenue: ifrs-full:Revenue; Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: ifrs-full:Revenue; Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: ifrs-full:Revenue; Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLoss; Revenue: ifrs-full:Revenue; Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare; Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/vs/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $44.1k | 34,177 |  | New +34,177 |
| [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $17.5k | 13,567 |  | New +13,567 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $11.6k | 9,063 |  | Reduced −13,636 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $1.3k | 1,000 |  | Added +999 |
| [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $625 | 488 |  | Added +405 |
| [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $397 | 311 |  | Unchanged |

## Recent filings

[All 236 filings](/companies/vs/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-10 | 12:21 ET | [8-K](/filings/0001213900-26-098586.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-098586 |
| 2026-08-14 | 17:39 ET | [10-Q](/filings/0001213900-26-089786.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089786 |
| 2026-07-24 | 00:00 ET | [8-K](/filings/0001213900-26-081070.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-081070 |
| 2026-07-16 | 20:01 ET | [8-K](/filings/0001213900-26-078691.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-078691 |
| 2026-06-29 | 10:25 ET | [8-K](/filings/0001213900-26-072834.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-072834 |
| 2026-06-22 | 13:21 ET | [DEF 14A](/filings/0001213900-26-070408.md) | Proxy statement, period 2026-07-16 | 0001213900-26-070408 |
| 2026-05-15 | 21:30 ET | [10-Q](/filings/0001213900-26-057987.md) | Quarterly report, period 2026-03-31 | 0001213900-26-057987 |
| 2026-05-05 | 20:01 ET | [8-K](/filings/0001213900-26-052173.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-26-052173 |
| 2026-04-16 | 10:41 ET | [8-K](/filings/0001213900-26-044306.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-044306 |
| 2026-04-15 | 20:45 ET | [10-K](/filings/0001213900-26-044110.md) | Annual report, period 2025-12-31 | 0001213900-26-044110 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-044110.md), filed Apr 15, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/dd919d08-204a-43b4-9fe5-42621c4bcf14)

## About the filer

- CIK: 1701963
- Tickers: VS
- Exchange: Nasdaq
- SIC code: 7374 Services-Computer Processing & Data Preparation
- State of incorporation: A1
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.